How Can Pharma Companies Save up to $45M in Early Drug Development?

Patheon’s Jennifer Therrien discusses findings of a Tufts Center for the Study of Drug Development (CSDD) study that reveals how pharmaceutical companies using a single-source outsourcing partner can achieve a net gain of $45 million in early drug development.

関連する施設紹介

関連する各種資料